Skip to main content
. Author manuscript; available in PMC: 2014 Dec 2.
Published in final edited form as: Semin Arthritis Rheum. 2014 May 9;44(2):170–174. doi: 10.1016/j.semarthrit.2014.05.007

Table 2.

Allopurinol dose and target SU in five European countries (31)

France
(n=193)
Germany
(n=208)
Italy
(n=194)
Spain
(n=197)
UK
(n=173)
Allopurinol dose
>300mg/d
5% 5% 10% 6% 34%
Percentage patients
not achieving SU
target (<6mg/dl)
54% 62% 53% 72% 31%